Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROI

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Nymox Pharmaceutical Corporation NYMX is 73.80%. Nymox Pharmaceutical's revenue for the same period is $3.20 million. The trailing-twelve-month return on investment at Meridian Bioscience, Inc. VIVO is 21.70%. Meridian Bioscience's PEG ratio is 1.88. The trailing-twelve-month return on investment at SurModics, Inc. SRDX is 11.20%. SurModics' EPS for the same period is $0.88. The trailing-twelve-month return on investment at Neogen Corp. NEOG is 9.30%. Neogen's profit margin for the same period is 11.60%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Trading IdeasDiagnostic SubstancesROIsmall-cap
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!